N H Bjarnason

Summary

Affiliation: Aarhus University Hospital
Country: Denmark

Publications

  1. ncbi Mechanism of circadian variation in bone resorption
    N H Bjarnason
    Center for Clinical and Basic Research, Ballerup, Denmark
    Bone 30:307-13. 2002
  2. ncbi Six and twelve month changes in bone turnover are related to reduction in vertebral fracture risk during 3 years of raloxifene treatment in postmenopausal osteoporosis
    N H Bjarnason
    Center for Clinical and Basic Research, Ballerup, Denmark
    Osteoporos Int 12:922-30. 2001
  3. ncbi Number of years since menopause: spontaneous bone loss is dependent but response to hormone replacement therapy is independent
    N H Bjarnason
    Center for Clinical and Basic Research, Ballerup, Denmark
    Bone 30:637-42. 2002
  4. doi Acute and long-term estradiol kinetics in smoking postmenopausal women
    N H Bjarnason
    Center for Clinical and Basic Research, Ballerup, Denmark
    Climacteric 15:449-54. 2012
  5. doi The influence of smoking on bone loss and response to nasal estradiol
    N H Bjarnason
    Center for Clinical and Basic Research, Ballerup
    Climacteric 12:59-65. 2009
  6. ncbi The influence of smoking on uterine bleeding during continuous and interrupted oral hormone therapy
    N H Bjarnason
    Center for Clinical and Basic Research, Ballerup
    Climacteric 10:480-90. 2007
  7. ncbi The influence of thinness and smoking on bone loss and response to hormone replacement therapy in early postmenopausal women
    N H Bjarnason
    Center for Clinical and Basic Research, Ballerup Byvej 222, Denmark
    J Clin Endocrinol Metab 85:590-6. 2000
  8. ncbi The influence of smoking on uterine bleeding during sequential oral hormone therapy
    N H Bjarnason
    Center for Clinical and Basic Research, Ballerup, Denmark
    Climacteric 10:147-54. 2007
  9. ncbi Smoking reduces breast tenderness during oral estrogen-progestogen therapy
    N H Bjarnason
    Center for Clinical and Basic Research, Ballerup, Denmark
    Climacteric 7:390-6. 2004
  10. ncbi Raloxifene and estrogen reduces progression of advanced atherosclerosis--a study in ovariectomized, cholesterol-fed rabbits
    N H Bjarnason
    Center for Clinical and Basic Research, Ballerup Byvej 222, 2750, Ballerup, Denmark
    Atherosclerosis 154:97-102. 2001

Detail Information

Publications13

  1. ncbi Mechanism of circadian variation in bone resorption
    N H Bjarnason
    Center for Clinical and Basic Research, Ballerup, Denmark
    Bone 30:307-13. 2002
    ..Both exogenous and endogenous insulin stimulation tests induced a reduction in bone resorption, but this was only partial when compared with the reduction observed during food intake...
  2. ncbi Six and twelve month changes in bone turnover are related to reduction in vertebral fracture risk during 3 years of raloxifene treatment in postmenopausal osteoporosis
    N H Bjarnason
    Center for Clinical and Basic Research, Ballerup, Denmark
    Osteoporos Int 12:922-30. 2001
    ..In contrast the change in BMD is not related to fracture risk. The strongest predictor for vertebral fracture is prevalent vertebral fracture...
  3. ncbi Number of years since menopause: spontaneous bone loss is dependent but response to hormone replacement therapy is independent
    N H Bjarnason
    Center for Clinical and Basic Research, Ballerup, Denmark
    Bone 30:637-42. 2002
    ..Whereas bone loss was significantly related to number of years since menopause, all HRT regimens applied arrested bone loss in healthy postmenopausal women, regardless of number of years since menopause...
  4. doi Acute and long-term estradiol kinetics in smoking postmenopausal women
    N H Bjarnason
    Center for Clinical and Basic Research, Ballerup, Denmark
    Climacteric 15:449-54. 2012
    ..Moreover, we wished to study estrogen concentrations over 2 years in smokers using ten or fewer cigarettes daily versus non-smokers in postmenopausal women on estrogen treatment...
  5. doi The influence of smoking on bone loss and response to nasal estradiol
    N H Bjarnason
    Center for Clinical and Basic Research, Ballerup
    Climacteric 12:59-65. 2009
    ..In addition, to observe the consequences of smoking on bone in untreated women...
  6. ncbi The influence of smoking on uterine bleeding during continuous and interrupted oral hormone therapy
    N H Bjarnason
    Center for Clinical and Basic Research, Ballerup
    Climacteric 10:480-90. 2007
    ..To study the influence of smoking on uterine bleeding patterns during continuous and interrupted oral hormone therapy (HT)...
  7. ncbi The influence of thinness and smoking on bone loss and response to hormone replacement therapy in early postmenopausal women
    N H Bjarnason
    Center for Clinical and Basic Research, Ballerup Byvej 222, Denmark
    J Clin Endocrinol Metab 85:590-6. 2000
    ..In conclusion, thinness and smoking are important risk factors for osteoporosis development, but are counteracted by hormone replacement therapy...
  8. ncbi The influence of smoking on uterine bleeding during sequential oral hormone therapy
    N H Bjarnason
    Center for Clinical and Basic Research, Ballerup, Denmark
    Climacteric 10:147-54. 2007
    ..To study the influence of smoking on uterine bleeding patterns during sequentially administered oral hormone therapy (HT)...
  9. ncbi Smoking reduces breast tenderness during oral estrogen-progestogen therapy
    N H Bjarnason
    Center for Clinical and Basic Research, Ballerup, Denmark
    Climacteric 7:390-6. 2004
    ..We wished to study the influence of smoking upon the occurrence of breast tenderness during oral estrogen-progestogen therapy (EPT)...
  10. ncbi Raloxifene and estrogen reduces progression of advanced atherosclerosis--a study in ovariectomized, cholesterol-fed rabbits
    N H Bjarnason
    Center for Clinical and Basic Research, Ballerup Byvej 222, 2750, Ballerup, Denmark
    Atherosclerosis 154:97-102. 2001
    ..01 for both) as compared to placebo...
  11. ncbi The effect of fluvastatin on parameters of bone remodeling
    N H Bjarnason
    Center for Clinical and Basic Research, Ballerup Byvej 222, DK 2750 Ballerup, Denmark
    Osteoporos Int 12:380-4. 2001
    ..We conclude that fluvastatin given in clinically relevant doses has no influence on parameters of bone remodeling. Other statins remain to be investigated...
  12. ncbi Associated response in bone mineral density and atherogenic lipid profile during treatment with two different selective estrogen receptor modulators: levormeloxifene and raloxifene
    A Bloch-Thomsen
    Center for Clinical and Basic Research, Ballerup, Denmark
    Climacteric 6:159-67. 2003
    ..Study 1 included 133 women treated with placebo or levormeloxifene in four different doses for 12 months, and study 2 included 248 women treated with raloxifene in three different doses or placebo for 24 months...
  13. doi Evaluation and registration of adverse events in clinical drug trials in migraine
    P Tfelt-Hansen
    Danish Headache Centre, Department of Neurology, University of Copenhagen, Glostrup Hospital, Copenhagen, Denmark
    Cephalalgia 28:683-8. 2008
    ..Tolerability may be indirectly assessed using measures of general well-being and eight such tools are presented. Finally, recommendations for reporting of adverse events are given...